HL Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.83M Buy
28,710
+17,403
+154% +$993K 0.03% 301
2018
Q4
$577K Sell
11,307
-2,028
-15% -$103K 0.01% 456
2018
Q3
$774K Sell
13,335
-81
-0.6% -$3.96K 0.01% 428
2018
Q2
$651K Sell
13,416
-1,800
-12% -$84K 0.01% 451
2018
Q1
$708K Sell
15,216
-1,446
-9% -$62.8K 0.01% 428
2017
Q4
$626K Sell
16,662
-10,020
-38% -$368K 0.01% 385
2017
Q3
$972K Sell
26,682
-2,745
-9% -$105K 0.02% 362
2017
Q2
$1.16M Buy
29,427
+12
+0% +$438 0.02% 320
2017
Q1
$922K Sell
29,415
-10,395
-26% -$325K 0.02% 360
2016
Q4
$1.24M Sell
39,810
-74,469
-65% -$2.41M 0.03% 292
2016
Q3
$4.59M Buy
114,279
+88,536
+344% +$3.33M 0.11% 124
2016
Q2
$856K Buy
25,743
+6,765
+36% +$231K 0.02% 353
2016
Q1
$558K Sell
18,978
-1,686
-8% -$46.5K 0.01% 404
2015
Q4
$544K Sell
20,664
-108,876
-84% -$2.83M 0.01% 425
2015
Q3
$3.07M Buy
129,540
+119,340
+1,170% +$2.88M 0.09% 147
2015
Q2
$242K Hold
10,200
0.01% 599
2015
Q1
$242K Hold
10,200
0.01% 609
2014
Q4
$217K Buy
+10,200
New +$205K 0.01% 635

Other funds holding EW

HL Financial Services's EW Position: Q1 2019 in Review

HL Financial Services increased its Edwards Lifesciences (EW) stake by 154% in Q1 2019, buying an estimated $993K and bringing the position to 28,710 shares worth $1.83M. The position accounts for 0.03% of the portfolio, ranked #301.

HL Financial Services first reported a position in EW in Q4 2014 and has held it in 18 quarters since. The position peaked at $4.59M in Q3 2016. 923 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • HL Financial Services held 28,710 shares of Edwards Lifesciences worth $1.83M as of Q1 2019.
  • HL Financial Services bought 17,403 Edwards Lifesciences shares in Q1 2019, an estimated $993K.
  • Edwards Lifesciences made up 0.03% of HL Financial Services's portfolio in Q1 2019, its #301 holding.
  • HL Financial Services first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 18 quarters since.
  • HL Financial Services's Edwards Lifesciences position peaked at $4.59M in Q3 2016.
  • 923 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.